Law ❯ Regulatory Affairs ❯ FDA Regulations ❯ Risk Evaluation and Mitigation Strategy

Mifepristone REMS

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions

The petition argues that decades-old FDA safeguards have become medically unnecessary obstacles to care during the agency’s safety review of the abortion pill.